Company: UPC
Filing Date: 2025-07-03
Form Type: 6-K
Source: 0001213900-25-061480
Chunk: 1

Company: Universe Pharmaceuticals INC
Filing Date: 2025-07-03
Form: 6-K
Chunk 1
---
 the six months ended March 31, 2024, primarily attributable 
 to the decreased average selling price and sales volume of Universe Pharmaceuticals INC’s (the “Company,” “we,”                            
 “our” and “us”)third-party products.                                                                                                       |

| ● | Loss from operations was                                                                                                          
 $2.3 million for the six months ended March 31, 2025, compared to a loss from operations of $1.7 million for the six months ended 
 March 31, 2024, due to a decrease in revenue and an increase in general and administrative expenses.                              |

| ● | Net loss was $3.3 million                                                                                                
 for the six months ended March 31, 2025, compared to a net loss of $2.4 million for the six months ended March 31, 2024. |

| ● | Loss per share was $9.44                                                                                                
 for the six months ended March 31, 2025, compared to loss per share of $393.26 for the six months ended March 31, 2024. |

Financial Results for the Six Months Ended March 31, 2025 Compared to the Six Months Ended March 31, 2024

Revenues

Total revenues decreased by $3,731,455, or 29.0%, to $9,152,915 for the six months ended March 31, 2025, from $12,884,370 for the six months ended March 31, 2024.

|                            |     | For the Six Months Ended March 31, 
 Revenue                            |      2025 |     | Cost of 
 revenue |           |     | Gross  
 margin |      |   |     | Revenue |       2024 |     | Cost of 
 revenue |           |     | Gross  
 margin |      |   |
|:---------------------------|:----|:-----------------------------------|----------:|:----|:--------|----------:|:----|:-------|-----:|:--|:----|:--------|-----------:|:----|:--------|----------:|:----|:-------|-----:|:--|
| TCMD products sales        |     | $                                  | 6,978,932 |     | $       | 4,640,381 |     |        | 33.5 | % |     | $       |  6,870,591 |     | $       | 5,602